<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical School</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5160CE88-742A-40D0-8C3B-711665EA2583"><gtr:id>5160CE88-742A-40D0-8C3B-711665EA2583</gtr:id><gtr:firstName>Ken</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A3C8FDF4-FD02-47CF-AB44-300B85DCB9B9"><gtr:id>A3C8FDF4-FD02-47CF-AB44-300B85DCB9B9</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:otherNames>Henry</gtr:otherNames><gtr:surname>Maxwell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C884A527-A140-4623-BCF3-E307CFEAD8B5"><gtr:id>C884A527-A140-4623-BCF3-E307CFEAD8B5</gtr:id><gtr:firstName>Carlos</gtr:firstName><gtr:surname>Caldas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1D368A50-E64B-4777-AC67-29507D354E8B"><gtr:id>1D368A50-E64B-4777-AC67-29507D354E8B</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>McCaskie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/07687B90-67AB-40C6-9AE9-F47B9B0C55D7"><gtr:id>07687B90-67AB-40C6-9AE9-F47B9B0C55D7</gtr:id><gtr:firstName>Berthold</gtr:firstName><gtr:surname>Gottgens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FM008975%2F1"><gtr:id>7F6D055F-5A91-4CA4-8162-B2D99D1F7C78</gtr:id><gtr:title>Establishment of the Cambridge Single Cell Analysis Clinical Core Facility [SCACCF]</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M008975/1</gtr:grantReference><gtr:abstractText>Recent technology developments have revolutionised our ability to characterize, quantify and isolate single cells. Examination of diseases at single cell resolution, both at diagnosis and after treatment, will transform the practice of molecular medicine by improving the quality of patient diagnosis, refining treatment options, monitoring of response to treatment, and detecting the emergence of resistance to treatment. Cambridge scientists have been at the forefront of basic research in single cell expression profiling and the analysis of circulating tumour DNA, as well as setting up local Biotech companies that develop novel single cell technologies. Here we propose to use MRC Infrastructure funding to create a new shared core facility for single cell analysis (the Cambridge Single Cell Analysis Clinical Core Facility [SCACCF]), which will serve all major molecular medicine programmes in Cambridge: cancer, neurosciences, immunity and inflammation, infectious diseases, stem cell and regenerative medicine, metabolic medicine and experimental therapeutics. SCACCF will be well placed to act as a hub for the UK and will work closely with our outstanding strategic partners in the Cambridge area (Babraham Institute, Wellcome Trust Sanger Institute, the European Bioinformatics Institute, the MRC Laboratory for Molecular Biology, major pharma &amp;amp; biotech), to bring their different capabilities to bear on clinical research challenges.</gtr:abstractText><gtr:technicalSummary>Recent technology developments have revolutionised our ability to characterize, quantify and isolate single cells. Examination of disease genotype/phenotype at single cell resolution, both at baseline and after therapeutic intervention, will transform the practice of molecular medicine in all its facets: diagnosis, therapeutic stratification, monitoring of response to treatment, and emergence of resistance. Cambridge scientists have been at the forefront of basic research in single cell expression profiling [Nat Methods 6:377-382, 2009; Cell Stem Cell 6:468-478, 2010] and the analysis of circulating tumour DNA [Nature 497:108-112, 2013; N Eng J Med 368: 1199-1209, 2013], as well as setting up local Biotech companies that develop novel single cell technologies [e.g. Sphere Fluidics]. Here we propose to use MRC Infrastructure funding to create a new shared core facility for single cell analysis that will serve all major molecular medicine programmes in Cambridge: cancer, neurosciences, immunity and inflammation, infectious diseases, stem cell and regenerative medicine, metabolic medicine and experimental therapeutics. The new Cambridge Single Cell Analysis Clinical Core Facility [SCACCF] will be well placed to act as a hub for the UK and will work closely with other centres of excellence. We are closely collocated with outstanding strategic partners (Babraham Institute, Wellcome Trust Sanger Institute, the European Bioinformatics Institute, the MRC Laboratory for Molecular Biology, major pharma &amp;amp; biotech; see attached letters of support). This initiative will be catalytic in bringing their different capabilities to bear on clinical research challenges.</gtr:technicalSummary><gtr:potentialImpactText>It is now widely recognised that single cell technology will transform molecular medicine. We interpret this current initiative as recognition by the MRC that substantial investment into state of the art equipment is now required to capitalise on the huge potential offered by single cell technology, especially for translational patient-centric research. We therefore propose to use MRC infrastructure funding under the Clinical Research Capabilities &amp;amp; Technologies initiative to create a new core facility in the Cambridge University Clinical School. This new Single Cell Analysis Clinical Core Facility [SCACCF] will be embedded in the Hospital to deliver new technologies at the clinical 'front end' of molecular medicine.

We have taken the following steps to maximise the potential impact of this investment:
1) Leveraged over &amp;pound;4,000,000 of existing funds within the school to ensure sustained running of this new facility, closely embedded with other core facilities such as cancer diagnostics and immune phenotyping. Much of this leverage is for staff costs, which cannot be applied for in this MRC call, but will be absolutely essential to run a successful core facility.
2) Engaged widely with all major molecular medicine programmes in Cambridge. Right from the outset therefore we have taken steps to maximise the chances that newly deployed single cell technology will have a wide impact to enhance clinical research across the entire clinical school
3) Secured support from research institutes and pharmaceutical/biotech industries in the Cambridge area (Babraham Institute, Wellcome Trust Sanger Institute, the European Bioinformatics Institute, the MRC Laboratory for Molecular Biology, Astra Zeneca, Sphere Fluidics; see attached letters of support). The new clinical core facility will be catalytic in bringing their different capabilities to bear on clinical research challenges, and therefore ensure sustained 'pull-through' of new technology into clinical care.
4) Establishd a network of scientists with world-leading expertise in both technical and bioinformatic aspects of single cell genomics, which will establish the new single cell clinical core facility here in Cambridge as a potential hub for the UK. We will endeavour to work closely with other centres of excellence, and this spirit of openness is evidenced already by our close interactions with all other applicants to this MRC initiative who are requesting installation of CyTOF technology.

To maximise the chances of single cell technology uptake, we will:
1) Establish a website explaining the potential uses of all the new technology we propose to install
2) Hold a number of seminars across Cambridge advertising the capabilities of the new facility
3) Establish a strong training programme, based on the template provide by the existing FACS phenotyping hub
4) Establish quarterly meetings with the EBI/Sanger single cell genomics core to keep us aware of the latest technology developments, and also offer our facility as a route towards early clinical translation
5) Establish a network of all single cell technology researchers in the Cambridge area (from the University, research institutes and industry), and hold an annual workshop similarto last year's Fluidigm European Single Cell Genomics workshop, which was held in Cambridge 
6) Engage with the other centres across the UK that may be funded through this initiative, to share latest protocols and also explore possible shared training activities.
7) Engage with other funders to enhance the capabilities beyond what is requested here.

Finally, engagement with the wider public forms an important part of our overall strategy. We will therefore shortlist the new Single Cell Core Facility for any public engagement opportunities, such as open days, disease-specific patient events in the hospital or events associated with the Science Week here in Cambridge.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3477700</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Single cell collaboration with EBI</gtr:description><gtr:id>DB867946-8DE9-44DE-82A4-75E731D9ED04</gtr:id><gtr:impact>The collaboration has produced the first transcriptome-wide in vivo view of early mesoderm formation during mammalian gastrulation as published in Scialdone et al. Nature 2016.</gtr:impact><gtr:partnerContribution>Joint supervision and design of the study; data analysis.</gtr:partnerContribution><gtr:piContribution>Single cell experimentation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>CRUK Cambridge Institute Annual International Symposium: Tumors at Cellular Resolution</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B676B48A-3AA9-49DB-9442-B4BF2D919072</gtr:id><gtr:impact>Two day scientific symposium bringing together international leaders considering key questions in applying single cell approaches to unanswered questions in cancer</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cruk.cam.ac.uk/symposium/home</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>9800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Centre</gtr:description><gtr:end>2022-06-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>766D4BBA-EF72-45A6-874D-AE947B1A49D1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intramural Institute</gtr:description><gtr:end>2022-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A24B3BC1-B30D-4741-90CD-0E0F1372279C</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>534778</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Research Grant</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P002293/1</gtr:fundingRef><gtr:id>CAD038F8-9FDB-4775-92F6-E71103502F1A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>297145</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Multiple Sclerosis Society Project Grants</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Multiple Sclerosis Society (MS Society)</gtr:fundingOrg><gtr:id>F0A474FC-6CE4-4093-B266-7F74C3B84C94</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1489605</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant</gtr:description><gtr:end>2022-01-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:fundingRef>C1163/A21762</gtr:fundingRef><gtr:id>33A28231-AED6-4518-B8A5-77D26DD3B7DA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>104000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Varsity Research Project Grant</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>8008CF79-70D0-4D73-BD30-1040F684BAF4</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>365508</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Skills Development Fellowship</gtr:description><gtr:end>2020-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P014178/1</gtr:fundingRef><gtr:id>11EEEDB3-2299-4B86-9D71-5DDA9297CAB8</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starting Grant</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>CC995CEE-351E-4C28-9DF8-58C0E0E64591</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Using the single cell data produced by the facility funded by this grant, BTR, an algorithm for training asynchronous Boolean models with single-cell expression data using a novel Boolean state space scoring function, was developed.</gtr:description><gtr:id>47F6BEFF-4F83-4F0C-B110-A9A751B059E1</gtr:id><gtr:impact>BTR is capable of refining existing Boolean models and reconstructing new Boolean models by improving the match between model prediction and expression data. It can be used to improve published Boolean models in order to generate new biological insights as demonstrated in Lim et al. BMC Bioinformatics 2016.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BTR</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The single cell facility established by this grant was used to sequence more than 1600 single haematopoietic stem and progenitor cells allowing the production of a diffusion map as published in Nestorowa et al. Blood 2016.</gtr:description><gtr:id>A09A2BAF-1EAF-4BDE-AB41-56B991BF5C3F</gtr:id><gtr:impact>The online diffusion map is the first of its kind for single haematopoietic stem and progenitor cell transcriptome data. Researchers can use it to visualise haematopoietic stem cell-to-progenitor transitions, highlight putative lineage branching points and identify lineage-specific transcriptional programs, which will have a strong impact on their future research.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Diffusion map of haematopoietic stem and progenitor cell differentiation</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://blood.stemcells.cam.ac.uk/single_cell_atlas.html</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Using the single cell facility funded by this grant, a pipeline was developed for the analysis of single cell qPCR data that uses the mathematics behind bursty expression to develop more accurate and robust algorithms for analyzing the origin of heterogeneity in experimental samples, specifically an algorithm for clustering cells by their bursting behavior (Simulated Annealing for Bursty Expression Clustering, SABEC) and a statistical tool for comparing the kinetic parameters of bursty expression across populations of cells (Estimation of Parameter changes in Kinetics, EPiK).</gtr:description><gtr:id>FF336BC8-CB7B-4CF0-BCF0-689EFC3B868C</gtr:id><gtr:impact>Using the pipeline, detailed information about gene regulatory mechanisms can be obtained simply from high throughput single cell gene expression data. As the availability of single cell genomic approaches rise, in part through the growth of facilities such as the one funded by this grant, it is likely to be widely adopted.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pipeline for the analysis of single cell qPCR data</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9FFAB35C-99FC-4AB6-A498-D90B0BE52580"><gtr:id>9FFAB35C-99FC-4AB6-A498-D90B0BE52580</gtr:id><gtr:title>Dissecting stem cell differentiation using single cell expression profiling.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e43ddbaffb2536bea263c184f18dd8f"><gtr:id>0e43ddbaffb2536bea263c184f18dd8f</gtr:id><gtr:otherNames>Moignard V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95FF5171-77C0-4441-8719-012A4C701D1A"><gtr:id>95FF5171-77C0-4441-8719-012A4C701D1A</gtr:id><gtr:title>Clonal Dynamics Reveal Two Distinct Populations of Basal Cells in Slow-Turnover Airway Epithelium.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da5ef6f5f08c3165df8afdfaeff76639"><gtr:id>da5ef6f5f08c3165df8afdfaeff76639</gtr:id><gtr:otherNames>Watson JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2211-1247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1995AA38-DD36-4DBD-A877-CACB6669B197"><gtr:id>1995AA38-DD36-4DBD-A877-CACB6669B197</gtr:id><gtr:title>Processing, visualising and reconstructing network models from single-cell data.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7fc6dbbd20b7c04d70606664a84f4d1"><gtr:id>f7fc6dbbd20b7c04d70606664a84f4d1</gtr:id><gtr:otherNames>Woodhouse S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AFB5C9A1-9EF2-4A43-8DD7-65F0178155DD"><gtr:id>AFB5C9A1-9EF2-4A43-8DD7-65F0178155DD</gtr:id><gtr:title>BTR: training asynchronous Boolean models using single-cell expression data.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9bb5e9d4d2626089677c545a3db4f6f"><gtr:id>a9bb5e9d4d2626089677c545a3db4f6f</gtr:id><gtr:otherNames>Lim CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0224C49-8FF6-467D-A23A-42ADC41E7CD1"><gtr:id>E0224C49-8FF6-467D-A23A-42ADC41E7CD1</gtr:id><gtr:title>Advancing haematopoietic stem and progenitor cell biology through single-cell profiling.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/195582d9f8adeed53c986a4c0b4ac44b"><gtr:id>195582d9f8adeed53c986a4c0b4ac44b</gtr:id><gtr:otherNames>Hamey FK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD12B76A-4BD1-4358-8A88-7E4DB6C42FC6"><gtr:id>BD12B76A-4BD1-4358-8A88-7E4DB6C42FC6</gtr:id><gtr:title>Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b63a208352b53e745b735dad97dff01"><gtr:id>8b63a208352b53e745b735dad97dff01</gtr:id><gtr:otherNames>Pietras EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A36DA4F-20D8-425D-B0F6-273A897B8079"><gtr:id>1A36DA4F-20D8-425D-B0F6-273A897B8079</gtr:id><gtr:title>Resolving early mesoderm diversification through single-cell expression profiling.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/978cb97711ed65ed85088ab4cf17356c"><gtr:id>978cb97711ed65ed85088ab4cf17356c</gtr:id><gtr:otherNames>Scialdone A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5ECA2AD7-A508-42C8-A04D-575C042EA807"><gtr:id>5ECA2AD7-A508-42C8-A04D-575C042EA807</gtr:id><gtr:title>Determining Physical Mechanisms of Gene Expression Regulation from Single Cell Gene Expression Data.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4b0911f14f87bfc5d0c4cb37c03af24d"><gtr:id>4b0911f14f87bfc5d0c4cb37c03af24d</gtr:id><gtr:otherNames>Ezer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E7AEA6B-7F12-4831-A397-3B23FFC8910F"><gtr:id>1E7AEA6B-7F12-4831-A397-3B23FFC8910F</gtr:id><gtr:title>The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52574b01e525544e39f0eeeb846c20f9"><gtr:id>52574b01e525544e39f0eeeb846c20f9</gtr:id><gtr:otherNames>Bonadies N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8288C7F-6125-475D-B792-A475C62C27E5"><gtr:id>E8288C7F-6125-475D-B792-A475C62C27E5</gtr:id><gtr:title>Decoding the regulatory network of early blood development from single-cell gene expression measurements.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e43ddbaffb2536bea263c184f18dd8f"><gtr:id>0e43ddbaffb2536bea263c184f18dd8f</gtr:id><gtr:otherNames>Moignard V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2183D88-3B6C-4E87-B828-D0B0D2C96A1B"><gtr:id>A2183D88-3B6C-4E87-B828-D0B0D2C96A1B</gtr:id><gtr:title>Index sorting resolves heterogeneous murine hematopoietic stem cell populations.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/677a9017f37de97ee1de59f62e12e024"><gtr:id>677a9017f37de97ee1de59f62e12e024</gtr:id><gtr:otherNames>Schulte R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/066B7397-FE57-4794-B129-DD18BB0CA470"><gtr:id>066B7397-FE57-4794-B129-DD18BB0CA470</gtr:id><gtr:title>Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c075dea7f8d686aa2b9d319a23e12a4"><gtr:id>6c075dea7f8d686aa2b9d319a23e12a4</gtr:id><gtr:otherNames>Wilson NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E196B4DE-54EE-41FE-9CDF-2D252A2256D3"><gtr:id>E196B4DE-54EE-41FE-9CDF-2D252A2256D3</gtr:id><gtr:title>Cytokine-induced megakaryocytic differentiation is regulated by genome-wide loss of a uSTAT transcriptional program.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/096b654a5ab601f5d0b52c2053001d8f"><gtr:id>096b654a5ab601f5d0b52c2053001d8f</gtr:id><gtr:otherNames>Park HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB790E0A-F522-455B-BD7E-338BF8ACADBC"><gtr:id>EB790E0A-F522-455B-BD7E-338BF8ACADBC</gtr:id><gtr:title>A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a95c2c99f358222b0b8f7be409554d0"><gtr:id>5a95c2c99f358222b0b8f7be409554d0</gtr:id><gtr:otherNames>Nestorowa S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/997C9CC4-0323-4E5F-B823-C617804F907F"><gtr:id>997C9CC4-0323-4E5F-B823-C617804F907F</gtr:id><gtr:title>An experimentally validated network of nine haematopoietic transcription factors reveals mechanisms of cell state stability.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/21be33c1d4780ecb49ca06502b9e5f48"><gtr:id>21be33c1d4780ecb49ca06502b9e5f48</gtr:id><gtr:otherNames>Sch?tte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M008975/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>